Showing results (191-200 of 239) with videos related to
Sort By:
Pageof 24
Scientific Reports|October 18, 2019
IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosisMayada Metwally, Khaled Thabet, Ali Bayoumi, et al.Journal of Clinical and Translational Hepatology|May 9, 2022
Redefinition of Fatty Liver Disease from NAFLD to MAFLD through the Lens of Drug Development and Regulatory ScienceYasser Fouad, Melissa Palmer, Minjun Chen, et al.Hepatobiliary Surgery and Nutrition|June 23, 2023
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney diseaseDan-Qin Sun, Giovanni Targher, Christopher D Byrne, et al.Alimentary Pharmacology & Therapeutics|January 6, 2022
Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysisGrazia Pennisi, Marco Enea, Manuel Romero-Gomez, et al.Hepatology (Baltimore, Md.)|July 18, 2018
ADAPT: An Algorithm Incorporating PRO-C3 Accurately Identifies Patients With NAFLD and Advanced FibrosisSamuel J Daniels, Diana J Leeming, Mohammed Eslam, et al.Journal of Gastroenterology and Hepatology|February 16, 2026
A Novel Fibroblast Activation Protein-Based Algorithm to Assess Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver DiseaseZiqi V Wang, Badwi B Boumelhem, Torsten Pennell, et al.Hepatology Communications|April 14, 2025
The global prevalence and impact of steatotic liver disease and viral infections: A systematic review and meta-analysisJiajing Li, Jiahua Zhou, Pengfei Li, et al.Liver International : Official Journal of the International Association for the Study of the Liver|March 1, 2024
Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohortLiang-Jie Tang, Dan-Qin Sun, Sherlot Juan Song, et al.Ebiomedicine|August 13, 2021
Copy number variation and expression of exportin-4 associates with severity of fibrosis in metabolic associated fatty liver diseaseMayada Metwally, Ali Bayoumi, Anis Khan, et al.Gastroenterology|May 8, 2018
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort StudyEduardo Vilar-Gomez, Luis Calzadilla-Bertot, Vincent Wai-Sun Wong, et al.Pageof 24